Bob Pisani explains how bad it's getting for active managers versus index funds, and how the regular trader can play it.
Tech investor Paul Meeks is buying a regional bank he believes could put him at the top of CNBC PRO's model portfolio competition.
Positive economic data and easing credit conditions have been catalysts for small-cap stock outperformance in the past, said the Fundstrat co-founder.
Don't start your trading day without finding out what CNBC's Jim Cramer is watching ahead of the opening bell.
CNBC's Jane Wells reports from Spaceport America in New Mexico on the future of space transportation.
Diana Farrell, JPMorgan Chase Institute CEO, discusses how more senior citizens in the U.S. are joining the gig economy to supplement their incomes.
CNBC's Rick Santelli reports the July reads on personal income up 0.4% and spending up 0.3%, both as analysts had expected.
There's a case for applying laws against profiteering to the drug industry, Dr. Joshua Sharfstein tells CNBC.
Bank of America Merrill Lynch sees markets swinging to a big supply deficit next year as demand remains robust, said Francisco Blanch.
This is how interest rates and the stock market can go both higher, says a top portfolio manager at ClearBridge.
The Fed could pull the rug out from under investors who are overlooking signs an interest rate hike is coming, economist Carl Tannenbaum says.
CNBC's Mike Santoli reports on the last five years in the markets and what investors can expect going forward.
Peter Schweizer, "Clinton Cash" Author, discusses the controversies surrounding Hillary Clinton including her emails and the relationship between the Clinton Foundation and the State Department.
CNBC's Dominic Chu speaks with Gary Player, Hall of Fame golfer, about the Gary Player Invitational charity tournament and the impact of golf's return to the Olympics in Rio.
Matt Smith, ClipperData Director of Commodity Research, discusses the current market environment for crude oil, prices at the pumps and what to expect from global producers.
Top tech investor Paul Meeks discusses what's working in his portfolio, including his views on FANG stocks versus "old tech" names.
Dr. Josh Sharfstein, Johns Hopkins University and Former FDA official, discusses the role of the FDA in drug pricing and competition in the pharmaceutical space.
CNBC's Meg Tirrell reports on the fears in the biotech market following the Mylan EpiPen pricing saga, as well as the news that Mylan will launch a generic EpiPen auto-injector.
CNBC's Diana Olick reports on increasing home prices and whether they signal a new bubble for the market.
Margaret Vitrano, ClearBridge Investments portfolio manager, and Mike Ryan, UBS chief investment strategist, discuss the likelihood of two Fed rate hikes this year.
Get the best of CNBC in your inbox
Joe Kernen is co-anchor of "Squawk Box," CNBC's signature morning program.
Becky Quick is co-anchor of "Squawk Box" and also anchor of the nationally syndicated "On the Money."
Andrew Ross Sorkin is a co-anchor of "Squawk Box," a financial columnist for "The New York Times" and the editor-at-large of NYT's DealBook.